Caricamento...
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Traditional drug development and discovery has not kept pace with threats from emerging and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV-2. Among other reasons, the exorbitant costs, high attrition rate and extensive periods of time from research to market approval...
Salvato in:
| Pubblicato in: | Pharmacol Ther |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier Inc.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220862/ https://ncbi.nlm.nih.gov/pubmed/34174275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2021.107930 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|